4 Results for "

FF2049

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "FF2049" in MCE Product Catalog:

Cat. No.: HY-168863
Target:  

PROTACs HDAC Apoptosis

Research Areas:  

Neurological Disease Cancer

FF2049 is a selective HDAC1-3 PROTAC degrader (with a DC50 of 257 nM against HDAC1). FF2049 recruits the E3 ligase FEM1B to mediate ubiquitination and proteasomal degradation of HDAC1-3. FF2049 induces cell cycle arrest and Apoptosis in cells. FF2049 can be used in research related to multiple myeloma, acute monocytic leukemia, triple-negative breast cancer and glioblastoma .
loading...
    loading...
Cat. No.: HY-168864
Research Areas:  

Cancer

HDAC ligand-5 is a template for the non-selective HDAC inhibitor Vorinostat (HY-10221). HDAC ligand-5 can serve as a ligand for target protein (Ligands for Target Protein for PROTAC) for the development of PROTAC HDAC degraders with antitumor activity. HDAC ligand-5 can be used for the synthesis of FF2049 (HY-168863) .
loading...
    loading...
Cat. No.: HY-168866
Research Areas:  

Cancer

E3 Ligase Ligand-linker Conjugate 160 is an E3 ligase ligand-linker conjugate. E3 Ligase Ligand-linker Conjugate 160 can be used to synthesize FF2049 (HY-168863) .
loading...
    loading...
Cat. No.: HY-168865
Target:  

Ligands for E3 Ligase

Research Areas:  

Cancer

E3 ligase Ligand 53 is a FEM1B ligand used to recruit Fem-1 homologue B (FEM1B) proteins. E3 ligase Ligand 53 can be attached to target protein ligands (e.g. HDAC1) via a linker to form PROTAC molecules (e.g. FF2049) .
loading...
    loading...